Heparin - CAS 9005-49-6
Catalog number: 9005-49-6
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C26H42N2O37S5
Molecular Weight:
1134.93
COA:
Inquire
Targets:
Others
Description:
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. The common form is the sodium salt form.
Purity:
>98%
Synonyms:
Heparin; Adomiparin; Bemiparin; Certoparin; Dalteparin; Eparina; Fraxiparin; M118; M-118; M 118; Nadroparine; Parvoparin; Thromboliquine;
MSDS:
Inquire
InChIKey:
HTTJABKRGRZYRN-UHFFFAOYSA-N
InChI:
InChI=1S/C26H42N2O37S5/c1-4(30)27-7-9(31)13(6(56-23(7)39)3-55-67(43,44)45)58-26-19(65-70(52,53)54)12(34)16(20(62-26)22(37)38)60-24-8(28-66(40,41)42)15(63-68(46,47)48)14(5(2-29)57-24)59-25-18(64-69(49,50)51)11(33)10(32)17(61-25)21(35)36/h5-20,23-26,28-29,31-34,39H,2-3H2,1H3,(H,27,30)(H,35,36)(H,37,38)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)
Canonical SMILES:
CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O
1.Heparin functionalisation of porous PLGA scaffolds for controlled, biologically relevant delivery of growth factors for soft tissue engineering
Geraldine Rohman, Simon C. Baker, Jennifer Southgate and Neil R. Cameron*. J. Mater. Chem., 2009, 19, 9265–9273
The introduction of amino-PEG moieties into PLGA scaffolds not only improved the poor hydrophilicity of the polymeric matrix (visual inspection of wettability), but also provided the necessary active sites for the further grafting of heparin. Heparin was grafted onto scaffolds by the process represented in Fig. 2. Heparin solution loaded over aminated PLGA scaffolds was allowed to react with EDAC as a coupling agent. Different concentrations of heparin solution were loaded over PLGA scaffolds and the process was also carried out with non-aminated control scaffolds to assess heparin adsorption (Table 1). For control scaffolds, the amount of adsorbed heparin was small for heparin loading solution concentrations ≤2.5 mg mL-1 and then the amount increased to 2.1 ± 0.4 mg mg-1 scaffold with a heparin loading solution concentration of 10 mg mL-1. The near absence of colour in foams after the toluidine blue assay showed that the non-covalently immobilised heparin was released completely from non-aminated scaffolds.
2.Bio-functionalization of ligand-free upconverting lanthanide doped nanoparticles for bio-imaging and cell targeting
Nicoleta Bogdan, John A. Capobianco*. Nanoscale, 2012, 4, 3647
The presence of heparin on the Ln3+-UCNPs enables functionalization with bFGF and at the same time maintains dispersibility in an aqueous medium. More importantly, the interaction of bFGF with heparin results in the required conformation of bFGF to interact with the bFGF receptors on the cell membrane.24 FTIR spectroscopy was used to show the successful binding of bFGF to the surface of the heparin coated nanoparticles. This was confirmed by the change in the peaks associated with the S=O stretching, that can be attributed to the interaction between the heparin and bFGF (Fig. 2). This observation agrees with previous studies where the importance of the 2-O- and N-sulfate groups of heparin for the interaction with the amino acid residues in heparin-binding regions of bFGF has been demonstrated. The zeta potential of the bFGF–heparin functionalized UCNPs was measured and a value of 6 mV was obtained. The concentration of bFGF bound on the surface of the heparin-capped Ln3+-UCNPs was obtained using the Bradford assay.
3.Mimicking the receptor-aided binding of HIV-1 TAT protein transduction domains to phospholipid monolayers at the air–water interface
Daehyun Hong, Kwanwoo Shin,* Michael James and Giyoong Tae. Soft Matter, 2012, 8, 8616–8623
Many growth factors and various ECM proteins have strong affinities to heparin via heparin-binding domains, and thus some of the main functions of heparin/heparan sulfate are to facilitate interactions between cells and growth factors or ECM proteins, and to preserve and prolong the effect of growth factors by sequestering them.15 Also, heparin and heparan sulfate have been considered as key GAG molecules that promote intracellular transport of transcription-activating factor (TAT), TAT-derived peptide (TAT-TDP) molecules and arginine-rich peptides. Heparin added to a medium has been reported to compete with these peptides for binding to the cell surface, thus inhibiting their intracellular transport. In addition, a deficiency in the expression of heparan sulfate on the cell surface significantly lowers the number of peptide molecules taken up by the cells.
4.Application of the ‘gate effect’ of a molecularly imprinted polymer grafted on an electrode for the real-time sensing of heparin in blood
Yasuo Yoshimi,* Kuniaki Sato, Masaki Ohshima and Elena Piletska. Analyst, 2013, 138, 5121–5128
The cyclic voltammogram of potassium ferrocyanide on the surface of the MIP–ITO or NIP–ITO electrode in the presence and absence of heparin is shown in Fig. 1. The current density of ferrocyanide at the MIP–ITO electrode was significantly smaller than that at the NIP–ITO or untreated ITO electrode: the peak current densities in the absence of heparin were 0.91± 0.08, 1.38±0.04 and 1.48±0.02 mA cm2, respectively, n = 3 each. The peak potentials were very similar among the electrodes (0.32–0.33 V versus Ag/AgCl). 0.04 units per mL of heparin increased the current at the MIP–ITO surface, while 40 units per mL of heparin decreased the current. The peak potential did not change in the presence of heparin. The current density at the NIP–ITO electrode was also not dependent on the presence of heparin.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


Gepotidacin
(CAS: 1075236-89-3)

Gepotidacin is a potent Type II DNA topoisomerase inhibitor. It is a novel antibacterial drug candidate. It is used for the treatment of gram positive bacterial...

CAS 3543-75-7 Bendamustine hydrochloride

Bendamustine hydrochloride
(CAS: 3543-75-7)

Bendamustine hydrochloride is the hydrochloride salt of bendamustine, a bifunctional mechlorethamine derivative with alkylator and antimetabolite activities. Be...

CAS 682741-29-3 HTS01037

HTS01037
(CAS: 682741-29-3)

HTS01037, a high-affinity ligand of adipocyte fatty acid binding protein (A-FABP/aP2) (Ki = 0.67 μM), and is a competitive antagonist of protein-protein interac...

CAS 1255517-77-1 UNC 0638

UNC 0638
(CAS: 1255517-77-1)

UNC 0638 is a selective inhibitor of G9a/EHMT2 and GLP histone lysine methyltransferases (IC50 values are < 15 nM and 19 nM for G9a and GLP respectively, and > ...

CAS 72093-21-1 Mastoparan

Mastoparan
(CAS: 72093-21-1)

Mastoparan, a tetradecapeptide which is a component of wasp venom, activates Gi and Go and has been shown to cause an increase in the production of Arachidonic ...

CAS 11018-89-6 Ouabain Octahydrate

Ouabain Octahydrate
(CAS: 11018-89-6)

Ouabain is a cardiac glycoside acting by Na(+)/K(+) ATPase, regulates transcription of MDR and MRP.

CAS 119757-73-2 Tautomycetin

Tautomycetin
(CAS: 119757-73-2)

Tautomycetin is a selective inhibitor of protein phosphatase (PP)1 (IC50 = 1.6 and 62 nM for PP1 and PP2, respectively) used as an immunosuppressive agent. Taut...

CAS 154-23-4 Catechin

Catechin
(CAS: 154-23-4)

(+)-Catechin is a flavonoid found primarily in higher woody plants as (+)-Catechin along with (-)-Epicatechin (cis form). Antidiarrheal.

Chemical Structure

CAS 9005-49-6 Heparin

Quick Inquiry

Verification code

Featured Items